公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients | I-CHUN CHEN ; Hu, Fu-Chang; CHING-HUNG LIN ; Huang, Shu-Min; DWANG-YING CHANG ; ANN-LII CHENG ; YEN-SHEN LU | Breast (Edinburgh, Scotland) | 2 | 2 | |
2023 | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | Peng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU | Cancer medicine | 0 | 0 | |
2023 | Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer | WEI-WU CHEN ; Hsiao, Wen; Dai, Ming-Shen; CHING-HUNG LIN ; DWANG-YING CHANG ; I-CHUN CHEN ; MING-YANG WANG ; Chang, Shu-Han; Huang, Shu-Min; ANN-LII CHENG ; Wu, Ko-Wen; Tan, Kien Thiam; YEN-SHEN LU | Breast cancer research and treatment | 0 | 0 | |
2015 | Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer | Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 鄭安理 | J. Clin. Oncol. | | | |
2024 | Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial | WEI-WU CHEN ; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; YA-FANG CHEN ; DWANG-YING CHANG ; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; ANN-LII CHENG ; YEN-SHEN LU | JAMA oncology | 1 | | |